Comparative analysis of liver functional reserve during lenvatinib and sorafenib for advanced hepatocellular carcinoma.

Takeshi TerashimaTatsuya YamashitaNoboru TakataTadashi ToyamaTetsuro ShimakamiHajime TakatoriKuniaki AraiKazunori KawaguchiKazuya KitamuraTaro YamashitaYoshio SakaiEishiro MizukoshiMasao HondaShuichi Kaneko

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2020)

More patients treated with lenvatinib for advanced HCC maintained their liver functional reserves compared with those treated with sorafenib. Maintaining the liver functional reserve contributed to better outcomes for patients with advanced HCC.

Keyphrases

metabolic syndrome
weight loss